AUS
NZ
UK
CA
USA
IND
_07_24_2025_05_14_18_005223.jpg)
_06_19_2026_12_34_15_139937.jpg)
Highlights
- Focus on lithium, iron ore, and mining services
- Exposure to global medical technology and SaaS markets
- Positioned among key ASX 200 stocks
In the diverse landscape of ASX 200 stocks, both Mineral Resources Ltd (MIN) and ResMed CDI (RMD) have drawn attention for their sector-specific strengths. These companies operate in entirely different domains—resources and healthcare technology—but each maintains a strategic presence in the Australian and global markets.
Mineral Resources Ltd (ASX:MIN): Diverse Mining Operations with Engineering Expertise
Mineral Resources Ltd (MIN) operates as a vertically integrated mining and mining services company. Headquartered in Western Australia, its portfolio includes lithium and iron ore extraction—two commodities central to global industrial and energy transitions.
What sets MIN apart is its ownership of CSI Mining Services, which enables the company to extend its infrastructure, construction, and operational capabilities beyond its own assets. CSI supports projects across Western Australia, Queensland, and the Northern Territory, contributing to wider industry capability while also reinforcing MIN’s operational flexibility.
A defining characteristic of Mineral Resources is its in-house engineering and construction model. This internal capability grants it added control over project execution and timelines, potentially reducing external dependency. As a constituent of the ASX 200 stocks, MIN represents a critical player in Australia's resource sector.
ResMed CDI (ASX:RMD): Expanding Global Reach in Respiratory Care and Health Tech
ResMed CDI (RMD), though headquartered overseas, maintains a significant presence on the ASX. The company provides solutions for sleep apnea and respiratory care, offering technologically advanced CPAP machines and ventilatory support systems.
RMD operates in over 140 countries and serves both clinical and home healthcare segments. Alongside its hardware products, it offers software platforms that support out-of-hospital healthcare providers, enhancing service delivery and patient management.
The business is divided into two core segments: Sleep and Respiratory Care, and Software as a Service (SaaS). Through this dual approach, RMD addresses both immediate patient needs and long-term digital healthcare transformation.
Valuation Perspective
Both MIN and RMD shares are currently priced below their long-term price-to-sales averages. This shift may reflect a range of factors, including changes in investor sentiment, evolving sector conditions, or broader economic cycles. While valuation ratios can offer early insights, they work best when assessed alongside broader industry context and operational developments.
Together, MIN and RMD highlight the breadth of sectors represented within the ASX. Their unique contributions—to mineral development and global health solutions—make them integral parts of Australia’s corporate ecosystem.
